Get the Stockscreener App
1.19
4.39%
0.05
Therapeuticsmd Inc stock is traded at $1.19, with a volume of 73,721.
It is up +4.39% in the last 24 hours and up +0.00% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.14
Open:
$1.14
24h Volume:
73,721
Relative Volume:
1.58
Market Cap:
$13.77M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.2453
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
+3.48%
1M Performance:
+0.00%
6M Performance:
+3.48%
1Y Performance:
-33.52%
1-Day Range:
$1.14
$1.23
1-Week Range:
$1.1192
$1.23
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.19 | 13.19M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
152.12 | 68.04B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.48 | 46.30B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.88 | 44.25B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.54 | 18.73B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
304.50 | 13.82B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
Should I hold or sell TherapeuticsMD Inc. stock in 2025Expert guidance for superior capital growth - jammulinksnews.com
Published on: 2025-07-28 06:06:00 - jammulinksnews.com
When is TherapeuticsMD Inc. stock expected to show significant growthUnstoppable trading performance - jammulinksnews.com
What are the latest earnings results for TherapeuticsMD Inc.Access high-yield investment alerts now - jammulinksnews.com
Is TherapeuticsMD Inc. a growth stock or a value stockUnlock real-time stock alerts for quick profits - jammulinksnews.com
How TherapeuticsMD Inc. stock performs during market volatilityHigh Return Potential - Newser
Why TherapeuticsMD Inc. stock attracts strong analyst attentionSwing Trade Signals - Newser
Is TherapeuticsMD Inc. a good long term investmentHigh-yield capital appreciation - PrintWeekIndia
What analysts say about TherapeuticsMD Inc. stockFree Stock Movement Tracking - Autocar Professional
What drives TherapeuticsMD Inc. stock priceRecord-breaking gains - PrintWeekIndia
Is TherapeuticsMD Inc. stock overhyped or has real potentialTremendous return on equity - jammulinksnews.com
TherapeuticsMD Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - Autocar Professional
TherapeuticsMD (NASDAQ:TXMD) Shares Down 0.8% – What’s Next? - Defense World
What makes TherapeuticsMD Inc. stock price move sharplyIntraday Trade Ideas - Newser
Mayne Pharma Group Unit Seeks Over $11.5 Million in Damages in US Court Complaint Against TherapeuticsMD - marketscreener.com
Mayne Pharma Files Legal Complaint Against TherapeuticsMD - TipRanks
StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World
TherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.com - Defense World
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.82%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):